MedPath

Retention rate of iguratimod with and without methotrexate in patients with rheumatoid arthritis.

Not Applicable
Conditions
rheumatoid arthritis
Registration Number
JPRN-UMIN000041767
Lead Sponsor
Department of Hematology and Rheumatology, Kindai University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
106
Inclusion Criteria

Not provided

Exclusion Criteria

Patients were excluded if they had been treated with biological DMARDs (bDMARDs). Patients with a connective tissue disease other than rheumatoid arthritis and patients previously treated with iguratimod were also excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath